Når produktet anvendes i henhold til den anbefalede dosering, opnås en steady- state- koncentration af meloxicam i plasma på behandlingens 2. dag.
When the product is used according to the recommended dosage regime, steady state concentrations of meloxicam in plasma are reached on the second day of treatment.